Asclera FDA Approval History
FDA Approved: Yes (First approved March 30, 2010)
Brand name: Asclera
Generic name: polidocanol
Dosage form: Injection
Company: Chemische Fabrik Kreussler & Co.
Treatment for: Varicose Veins
Asclera (polidocanol) is a sclerosing agent used for the treatment of varicose veins.
Development timeline for Asclera
|Mar 31, 2010||Approval FDA Approves Asclera to Treat Small Varicose Veins|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.